DADATA·ANALYSIS
FREE
company · cik 1385818

AYTU BIOPHARMA, INC

AYTUNasdaqSIC 2834public
financials · annual · usd2026
Revenue$29.1M
Net income-$10.6M
Total assets$122.0M
Total liabilities$97.1M
Equity$14.2M
LT debt$10.0M
Operating cash$3.1M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1